{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:27Z","timestamp":1786119207275,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/wnf.0b013e318074dd4f","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:55:28Z","timestamp":1236192928000},"page":"345-349","source":"Crossref","is-referenced-by-count":29,"title":["Zonisamide for Essential Tremor"],"prefix":"10.1097","volume":"30","author":[{"given":"William G.","family":"Ondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00183-9","article-title":"Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures.","volume":"116","author":"Ueda","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial.","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"R5-4-20210203","first-page":"1131","article-title":"Tremor Research Group. The Tremor Rating Scale (TRS).","volume":"19","author":"Tintner","year":"2004","journal-title":"Mov Disord"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","article-title":"A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor.","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Mov Disord"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","article-title":"Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.","volume":"11","author":"Morita","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"R8-4-20210203","first-page":"685","article-title":"Effect of zonisamide on resting tremor resistant to antiparkinsonian medication.","volume":"55","author":"Nakanishi","year":"2003","journal-title":"No To Shinkei"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"The Japan Zonisamide on PDSG. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-200711000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:44:27Z","timestamp":1786038267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200711000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318074dd4f","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}